antisense pharma...connection?, page-7

Nah......my info is from i hour ago.....ISIS is generating a great deal of interest....


Strong Buy
No Dose Limiting Toxoicity has been Observed/Complete Response Rate Observed to Date is Higher than-
Expected



..and the FDA asked Isis for an Oncology study for Mipo...This type of news should clear a lot of worrisome hurdles and set a new trend of thinking followed by actions from future partners and present partners. Do You Recall that DNA was bought out from Roche for 46.5 billion and look at these results from a start-up company. Once Isis announces its rights to exercise its options to buy into OncoGenex,what will Isis's shares be valued at? Is there a Next Generation drug, perhaps with a Nano formulation???